Continuation of dabigatran therapy in "real-world" practice in Hong Kong

Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encourage long-term...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2014-08, Vol.9 (8), p.e101245
Hauptverfasser:	Ho, Mei Han, Ho, Chi Wai, Cheung, Emmanuel, Chan, Pak Hei, Hai, Jo Jo, Chan, Koon Ho, Chan, Esther W, Leung, Gilberto Ka Kit, Tse, Hung Fat, Siu, Chung Wah
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Analysis Anticoagulants Antithrombins - administration & dosage Antithrombins - adverse effects Antithrombins - therapeutic use Atrial fibrillation Atrial Fibrillation - complications Audio frequencies Benzimidazoles - administration & dosage Benzimidazoles - adverse effects Benzimidazoles - therapeutic use beta-Alanine - administration & dosage beta-Alanine - adverse effects beta-Alanine - analogs & derivatives beta-Alanine - therapeutic use Bleeding Cardiac arrhythmia Cardiology Care and treatment Clinical medicine Cost analysis Dabigatran Diabetes Dyspepsia FDA approval Female Fibrillation Follow-Up Studies Glomerular filtration rate Heart failure Hemorrhage Hemorrhage - etiology Hong Kong Humans Hypertension Identification methods Inhibitors Ischemia Male Medical imaging Medicine Medicine and Health Sciences Middle Aged NMR Nuclear magnetic resonance Patients Prevention Proton pump inhibitors Risk analysis Risk Factors Side effects Stroke Stroke - diagnosis Stroke - etiology Stroke - mortality Stroke - prevention & control Therapy Thrombin Tomography Treatment Outcome Warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!